Lymphohistiocytosis, Hemophagocytic Recruiting Phase 3 Trials for Pegaspargase (DB00059)

Also known as: Hemophagocytic Lymphohistiocytosis / Erythrophagia / Histiocytosis hematophagic / Histiocytosis haematophagic / Haemophagocytosis / Hemophagocytosis / Haemophagocytic lymphohistiocytosis / Familial hemophagocytic reticulosis

IndicationStatusPhase
DBCOND0001493 (Lymphohistiocytosis, Hemophagocytic)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02631109L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic LymphohistiocytosisTreatment
NCT02912702L-DEP as an Initial Treatment for EBV-HLHTreatment